A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects

NCT02136316 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Pharmacokinetics of ASP7962

Interventions

DRUG: ASP7962
DRUG: Placebo

Sponsor

Astellas Pharma Europe B.V.